Source: Annual Congress 2013 –COPD treatment
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Grabicki, H. Batura-Gabryel, B. Kuznar-Kaminska, B. Brajer-Luftmann (Poznan, Poland). NT-proBNP in assessment of pulmonary hypertension in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 3677

Member's Comments

No comment yet.

Related content which might interest you: Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators Source: International Congress 2014 – Clinical presentations Year: 2014 Secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007 Pulmonary embolism in COPD patients Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 microRNA profile in COPD patients with and without pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006 CT predictors of pulmonary hypertension in patients with severe COPD Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD? Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013